HEMISPHERE ENERGY CORP (HME.CA) Fundamental Analysis & Valuation
TSX-V:HME • CA4236301020
Current stock price
2.88 CAD
+0.07 (+2.49%)
Last:
This HME.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. HME.CA Profitability Analysis
1.1 Basic Checks
- HME had positive earnings in the past year.
- HME had a positive operating cash flow in the past year.
- Of the past 5 years HME 4 years were profitable.
- HME had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of HME (24.66%) is better than 97.60% of its industry peers.
- Looking at the Return On Equity, with a value of 38.33%, HME belongs to the top of the industry, outperforming 98.56% of the companies in the same industry.
- HME has a better Return On Invested Capital (31.98%) than 99.52% of its industry peers.
- HME had an Average Return On Invested Capital over the past 3 years of 38.31%. This is significantly above the industry average of 6.78%.
- The last Return On Invested Capital (31.98%) for HME is well below the 3 year average (38.31%), which needs to be investigated, but indicates that HME had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.66% | ||
| ROE | 38.33% | ||
| ROIC | 31.98% |
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
1.3 Margins
- The Profit Margin of HME (30.81%) is better than 95.19% of its industry peers.
- HME's Profit Margin has improved in the last couple of years.
- HME's Operating Margin of 42.73% is amongst the best of the industry. HME outperforms 92.79% of its industry peers.
- In the last couple of years the Operating Margin of HME has grown nicely.
- HME has a Gross Margin of 60.82%. This is in the better half of the industry: HME outperforms 79.81% of its industry peers.
- HME's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 42.73% | ||
| PM (TTM) | 30.81% | ||
| GM | 60.82% |
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
2. HME.CA Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), HME is creating value.
- HME has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, HME has more shares outstanding
- The debt/assets ratio for HME has been reduced compared to a year ago.
2.2 Solvency
- HME has an Altman-Z score of 5.96. This indicates that HME is financially healthy and has little risk of bankruptcy at the moment.
- HME has a better Altman-Z score (5.96) than 85.58% of its industry peers.
- HME has a debt to FCF ratio of 0.07. This is a very positive value and a sign of high solvency as it would only need 0.07 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 0.07, HME belongs to the top of the industry, outperforming 96.63% of the companies in the same industry.
- A Debt/Equity ratio of 0.03 indicates that HME is not too dependend on debt financing.
- HME's Debt to Equity ratio of 0.03 is fine compared to the rest of the industry. HME outperforms 75.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.07 | ||
| Altman-Z | 5.96 |
ROIC/WACC4.02
WACC7.96%
2.3 Liquidity
- HME has a Current Ratio of 1.41. This is a normal value and indicates that HME is financially healthy and should not expect problems in meeting its short term obligations.
- HME's Current ratio of 1.41 is fine compared to the rest of the industry. HME outperforms 69.71% of its industry peers.
- A Quick Ratio of 1.41 indicates that HME should not have too much problems paying its short term obligations.
- HME's Quick ratio of 1.41 is fine compared to the rest of the industry. HME outperforms 71.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.41 | ||
| Quick Ratio | 1.41 |
3. HME.CA Growth Analysis
3.1 Past
- The earnings per share for HME have decreased by -9.09% in the last year.
- Measured over the past years, HME shows a very strong growth in Earnings Per Share. The EPS has been growing by 80.04% on average per year.
- Looking at the last year, HME shows a decrease in Revenue. The Revenue has decreased by -0.77% in the last year.
- HME shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.97% yearly.
EPS 1Y (TTM)-9.09%
EPS 3Y72.84%
EPS 5Y80.04%
EPS Q2Q%-22.22%
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y32.32%
Revenue growth 5Y25.97%
Sales Q2Q%-13.24%
3.2 Future
- The Earnings Per Share is expected to decrease by -15.87% on average over the next years. This is quite bad
- HME is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.01% yearly.
EPS Next Y-12.61%
EPS Next 2Y-7.35%
EPS Next 3Y-6.72%
EPS Next 5Y-15.87%
Revenue Next Year-5.85%
Revenue Next 2Y-6.12%
Revenue Next 3Y-4.8%
Revenue Next 5Y-7.01%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. HME.CA Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 9.60 indicates a reasonable valuation of HME.
- Based on the Price/Earnings ratio, HME is valued a bit cheaper than the industry average as 78.85% of the companies are valued more expensively.
- HME is valuated cheaply when we compare the Price/Earnings ratio to 24.88, which is the current average of the S&P500 Index.
- The Price/Forward Earnings ratio is 10.17, which indicates a very decent valuation of HME.
- Based on the Price/Forward Earnings ratio, HME is valued a bit cheaper than 77.88% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 22.19. HME is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.6 | ||
| Fwd PE | 10.17 |
4.2 Price Multiples
- HME's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. HME is cheaper than 90.87% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of HME indicates a rather cheap valuation: HME is cheaper than 93.75% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.22 | ||
| EV/EBITDA | 4.67 |
4.3 Compensation for Growth
- The excellent profitability rating of HME may justify a higher PE ratio.
- HME's earnings are expected to decrease with -6.72% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.12
EPS Next 2Y-7.35%
EPS Next 3Y-6.72%
5. HME.CA Dividend Analysis
5.1 Amount
- HME has a Yearly Dividend Yield of 3.56%. Purely for dividend investing, there may be better candidates out there.
- HME's Dividend Yield is a higher than the industry average which is at 4.41.
- Compared to an average S&P500 Dividend Yield of 1.89, HME pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.56% |
5.2 History
- HME has been paying a dividend for over 5 years, so it has already some track record.
- HME has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- HME pays out 60.59% of its income as dividend. This is not a sustainable payout ratio.
DP60.59%
EPS Next 2Y-7.35%
EPS Next 3Y-6.72%
HME.CA Fundamentals: All Metrics, Ratios and Statistics
TSX-V:HME (3/27/2026, 7:00:00 PM)
2.88
+0.07 (+2.49%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-25 2025-11-25/bmo
Earnings (Next)04-15 2026-04-15/amc
Inst Owners0.94%
Inst Owner ChangeN/A
Ins Owners16.08%
Ins Owner ChangeN/A
Market Cap271.67M
Revenue(TTM)98.24M
Net Income(TTM)30.27M
Analysts84
Price Target2.96 (2.78%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.56% |
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP60.59%
Div Incr Years2
Div Non Decr Years2
Ex-Date02-12 2026-02-12 (0.025)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.91%
Min EPS beat(2)-2.91%
Max EPS beat(2)-2.91%
EPS beat(4)1
Avg EPS beat(4)-1.48%
Min EPS beat(4)-2.91%
Max EPS beat(4)2.8%
EPS beat(8)3
Avg EPS beat(8)-2.87%
EPS beat(12)5
Avg EPS beat(12)1.35%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.89%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)5.99%
Revenue beat(4)3
Avg Revenue beat(4)2.9%
Min Revenue beat(4)-0.21%
Max Revenue beat(4)5.99%
Revenue beat(8)5
Avg Revenue beat(8)0.35%
Revenue beat(12)7
Avg Revenue beat(12)-0.67%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.73%
PT rev (3m)19.59%
EPS NQ rev (1m)20%
EPS NQ rev (3m)33.33%
EPS NY rev (1m)1.82%
EPS NY rev (3m)1.82%
Revenue NQ rev (1m)2.45%
Revenue NQ rev (3m)2.29%
Revenue NY rev (1m)-0.27%
Revenue NY rev (3m)-0.03%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.6 | ||
| Fwd PE | 10.17 | ||
| P/S | 2.77 | ||
| P/FCF | 6.22 | ||
| P/OCF | 4.89 | ||
| P/B | 3.44 | ||
| P/tB | 3.44 | ||
| EV/EBITDA | 4.67 |
EPS(TTM)0.3
EY10.42%
EPS(NY)0.28
Fwd EY9.84%
FCF(TTM)0.46
FCFY16.08%
OCF(TTM)0.59
OCFY20.46%
SpS1.04
BVpS0.84
TBVpS0.84
PEG (NY)N/A
PEG (5Y)0.12
Graham Number2.38
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.66% | ||
| ROE | 38.33% | ||
| ROCE | 42.48% | ||
| ROIC | 31.98% | ||
| ROICexc | 43.34% | ||
| ROICexgc | 43.34% | ||
| OM | 42.73% | ||
| PM (TTM) | 30.81% | ||
| GM | 60.82% | ||
| FCFM | 44.47% |
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
ROICexc(3y)41.04%
ROICexc(5y)31.02%
ROICexgc(3y)41.04%
ROICexgc(5y)31.02%
ROCE(3y)50.88%
ROCE(5y)39%
ROICexgc growth 3Y12.92%
ROICexgc growth 5Y20.01%
ROICexc growth 3Y12.92%
ROICexc growth 5Y20.01%
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.07 | ||
| Debt/EBITDA | 0.04 | ||
| Cap/Depr | 105.19% | ||
| Cap/Sales | 12.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 104.31% | ||
| Profit Quality | 144.34% | ||
| Current Ratio | 1.41 | ||
| Quick Ratio | 1.41 | ||
| Altman-Z | 5.96 |
F-Score6
WACC7.96%
ROIC/WACC4.02
Cap/Depr(3y)210.69%
Cap/Depr(5y)187.35%
Cap/Sales(3y)20.24%
Cap/Sales(5y)19.51%
Profit Quality(3y)104.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.09%
EPS 3Y72.84%
EPS 5Y80.04%
EPS Q2Q%-22.22%
EPS Next Y-12.61%
EPS Next 2Y-7.35%
EPS Next 3Y-6.72%
EPS Next 5Y-15.87%
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y32.32%
Revenue growth 5Y25.97%
Sales Q2Q%-13.24%
Revenue Next Year-5.85%
Revenue Next 2Y-6.12%
Revenue Next 3Y-4.8%
Revenue Next 5Y-7.01%
EBIT growth 1Y-3.75%
EBIT growth 3Y35.09%
EBIT growth 5Y31.88%
EBIT Next Year34.08%
EBIT Next 3Y-0.98%
EBIT Next 5Y-5.77%
FCF growth 1Y130.83%
FCF growth 3Y57.01%
FCF growth 5YN/A
OCF growth 1Y39.86%
OCF growth 3Y36.33%
OCF growth 5Y34.82%
HEMISPHERE ENERGY CORP / HME.CA Fundamental Analysis FAQ
What is the ChartMill fundamental rating of HEMISPHERE ENERGY CORP (HME.CA) stock?
ChartMill assigns a fundamental rating of 7 / 10 to HME.CA.
What is the valuation status for HME stock?
ChartMill assigns a valuation rating of 7 / 10 to HEMISPHERE ENERGY CORP (HME.CA). This can be considered as Undervalued.
Can you provide the profitability details for HEMISPHERE ENERGY CORP?
HEMISPHERE ENERGY CORP (HME.CA) has a profitability rating of 9 / 10.
What is the financial health of HEMISPHERE ENERGY CORP (HME.CA) stock?
The financial health rating of HEMISPHERE ENERGY CORP (HME.CA) is 8 / 10.
Can you provide the dividend sustainability for HME stock?
The dividend rating of HEMISPHERE ENERGY CORP (HME.CA) is 4 / 10 and the dividend payout ratio is 60.59%.